SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Natural Aorta Grafts Have Few Side Effects for Infection-Prone Patients, UT Southwestern Medical Center Researchers Report
September 13, 2007
 · 
1 min read
Lone Star Bio
Women Less Likely Than Men to Change Habits That Increase Heart-Disease Risk
September 13, 2007
 · 
1 min read
Lone Star Bio
Customized Virus Kills Brain Tumor Stem Cells That Drive Lethal Cancer, M. D. Anderson Cancer Center Study
September 12, 2007
 · 
1 min read
Lone Star Bio
Microarray Provides Three Genomic Guides to Breast Cancer Treatment Decisions, University of Texas M. D. Anderson Cancer Center Study
September 12, 2007
 · 
1 min read
Lone Star Bio
‘Rain Man’ Mice Provide Model for Autism, UT Southwestern Medical Center Study
September 10, 2007
 · 
1 min read
Lone Star Bio
Embryonic Stem Cells Used to Grow Cartilage
September 6, 2007
 · 
1 min read
Lone Star Bio
UT Southwestern Medical Center’s New Imaging Technique Reveals Fatty Hearts in Pre-Diabetics
September 5, 2007
 · 
1 min read
Lone Star Bio
New Male Sling Procedure Helps Prostate Cancer Survivors Who Suffer from Urinary Incontinence
August 29, 2007
 · 
1 min read
Lone Star Bio
Circulating Fats Kill Transplanted Pancreas Cells, UT Southwestern Medical Center Study Shows
August 28, 2007
 · 
1 min read
Lone Star Bio
New Cancer Weapon: Nuclear Nanocapsules
August 24, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More